Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TS03 Inc Trust Units TSTIF

Healthcare Medical Instruments & Supplies


GREY:TSTIF - Post by User

TS03 Inc Trust Units > 4th quarter and 2017 visibility?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by GoPats1on Jan 10, 2017 11:05am
162 Views
Post# 25688215

RE:RE:RE:4th quarter and 2017 visibility?

RE:RE:RE:4th quarter and 2017 visibility?He did not say that he would disclose sell through. He tried as best he could through color commentary by 3 top Getinge executives and a video testimonial at the investor day by the head of the sterilization department of a recent US hospital install. He did state that his expectation was for a strong 4Q from Getinge. I can't square the fact that purchase orders for 4Q/3Q were flat. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities